Nandhakumar Suresh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nandhakumar Suresh has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bhuvaneshwari Jayachandran
Cancer biology lab Center for Molecular and Nanomedical Sciences Sathyabama Institute of Science and Technology Chennai, Tamil Nadu 600119 India
1 shared publication - Chirag D. Patel
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, Near University Circle, Vallabh Vidyanagar-388120, Gujarat, India
1 shared publication - Disha P. Vala
Department of Chemistry, Sardar Patel University
1 shared publication - Hitendra M. Patel
Department of Chemistry Sardar Patel University Vallabh Vidyanagar Gujarat India
1 shared publication - Madan Kumar Arumugam
Cancer Biology lab, Centre for Molecular and Nanomedical Sciences, Sathyabama Institute of Science and Technology, Chennai 600119, Tamil Nadu, India
1 shared publication - Mahesh Narayan
The University of Texas at El Paso, USA
1 shared publication
Latest Publications
- 13 November 2024
- Published by Wiley in ChemMedChem
- Vol. 20 (2) , e202400595
Acetic Acid‐Driven One‐Pot Synthesis of 4,7‐dihydro‐[1,2,3]thiadiazolo[5,4‐b]pyridine‐6‐carboxamides and Pharmacological Evaluations
A diverse set of 4,7‐dihydro‐[1,2,3]thiadiazolo[5,4‐b]pyridine‐6‐carboxamides 4(a–o) was synthesized via a one‐pot reaction of 5‐amino‐[1,2,3]thiadiazole, various aromatic aldehydes, and different acetoacetanilides, using glacial acetic acid. The resulting compounds were obtained in moderate to good yields. All the newly synthesized compounds were evaluated for their antimicrobial activity. Among them, compound 4 e demonstrated superior efficacy against the Salinivibrio proteolyticus strain of Gram‐negative bacteria compared to ciprofloxacin. Compound 4 d exhibited the highest potency against the fungal strain Candida albicans, surpassing amphotericin B. The physicochemical characteristics of 4 d and 4 e were assessed. According to docking analysis, DHTDAPy 4 e shows a higher binding affinity of −7.2 kcal/mol in the binding cavity of the receptor. These findings illustrate the safety, tolerability, and potency of the newly synthesized DHTDAPy compounds against fungal and bacterial infections.
- 13 November 2024
- Published by Wiley in ChemMedChem
- Vol. 20 (2) , e202400595
Acetic Acid‐Driven One‐Pot Synthesis of 4,7‐dihydro‐[1,2,3]thiadiazolo[5,4‐b]pyridine‐6‐carboxamides and Pharmacological Evaluations
A diverse set of 4,7‐dihydro‐[1,2,3]thiadiazolo[5,4‐b]pyridine‐6‐carboxamides 4(a–o) was synthesized via a one‐pot reaction of 5‐amino‐[1,2,3]thiadiazole, various aromatic aldehydes, and different acetoacetanilides, using glacial acetic acid. The resulting compounds were obtained in moderate to good yields. All the newly synthesized compounds were evaluated for their antimicrobial activity. Among them, compound 4 e demonstrated superior efficacy against the Salinivibrio proteolyticus strain of Gram‐negative bacteria compared to ciprofloxacin. Compound 4 d exhibited the highest potency against the fungal strain Candida albicans, surpassing amphotericin B. The physicochemical characteristics of 4 d and 4 e were assessed. According to docking analysis, DHTDAPy 4 e shows a higher binding affinity of −7.2 kcal/mol in the binding cavity of the receptor. These findings illustrate the safety, tolerability, and potency of the newly synthesized DHTDAPy compounds against fungal and bacterial infections.